Keywords: آتورواستاتین; Atorvastatin; carotid plaque; carotid stenosis; carotid ultrasound; gray-scale median; stroke
مقالات ISI آتورواستاتین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آتورواستاتین; Atorvastatin; Lipoprotein subfractions; LDL-receptor activity; Polygenic hypercholesterolemia; Hypercholesterolemia; Familial combined hyperlipoproteinemia; Familial hypercholesterolemia;
Keywords: آتورواستاتین; Atorvastatin; Coronary artery bypass; Depression; Simvastatin;
Keywords: آتورواستاتین; Hyperhomocysteinemia; Atorvastatin; Simvastatin; Oxidative stress
Keywords: آتورواستاتین; Phytosterols; Atorvastatin; Ezetimibe; Cholesterol synthesis; Cholesterol absorption;
Keywords: آتورواستاتین; Atorvastatin; Imipenem; Lung injury; Sepsis;
Keywords: آتورواستاتین; ACh; acetylcholine; AR; adrenergic receptor; ATR; atorvastatin; CLP; cecal ligation and puncture; eNOS; endothelial nitric oxide synthase; GRK2; G-protein receptor kinase 2; IMP; imipenem; iNOS; inducible nitric oxide synthase; MKHS; modified Krebs-Hens
Keywords: آتورواستاتین; Atorvastatin; Salting out assisted solvent extraction; Clean up; Preconcentration; Serum
Keywords: آتورواستاتین; Chronic subdural hematoma; Atorvastatin; Conservative therapy; Clinical trial; Absorption; Prospective study;
Keywords: آتورواستاتین; Brain; Cholesterol; Atorvastatin; Lipid; Hypercholesterolemia; Pharmacology
Keywords: آتورواستاتین; Statins; Atorvastatin; Simvastatin; High-density-lipoprotein cholesterol; Diabetes mellitus; Meta-analysis
Keywords: آتورواستاتین; Arterial calcification; Atorvastatin; Calcifying nanoparticles; Hyperplasia;
Keywords: آتورواستاتین; Liver; Ischemia/Reperfusion; Atorvastatin; Rat; Pro-inflammatory cytokines; Endothelial adhesion molecules
Keywords: آتورواستاتین; Asthma; Atorvastatin; Mice;
Keywords: آتورواستاتین; atorvastatin; beta-cell function; dyslipidemia; insulin resistance; type 2 diabetes mellitusatorvastatine; fonctionnement des cellules bêta; dyslipidémie; insulinorésistance; diabète sucré de type 2
Keywords: آتورواستاتین; Intensive statin therapy; Atorvastatin; Atherosclerotic intracranial arterial stenosis; Computed tomography angiography; Computed tomography perfusion
Keywords: آتورواستاتین; Statin; Atorvastatin; Antidepressant-like effect; Tail suspension test; Serotonergic system; Serotonin
Keywords: آتورواستاتین; Subtraction; Quotient; Standard addition; Aspirin; Atorvastatin; Clopidgrel;
Keywords: آتورواستاتین; Chronic constriction injury; Neuropathic pain; Hyperalgesia; Oxidative stress; Atorvastatin
Keywords: آتورواستاتین; Lithium; Atorvastatin; Nitric oxide; Memory; Mice
Keywords: آتورواستاتین; Subdural hematoma; Atorvastatin; Inflammation; Angiogenesis; Cytokine; ELISA;
Keywords: آتورواستاتین; Ultrasound images; Endothelial function; Endothelium-dependent vasodilation; Atorvastatin; Motion detection;
Keywords: آتورواستاتین; Carbon nanomaterials; Carbon nanotubes; Polypyrrole; Atorvastatin; Carbon nanoparticles
Keywords: آتورواستاتین; ACh; acetylcholine; ATV; atorvastatin; CMC; carboxymethyl cellulose; CRP; C-reactive protein; CVD; cardiovascular disease; cNOS; constitutive nitric oxide synthase; ECs; endothelial cells; eNOS; endothelial nitric oxide synthase; ERK; extracellular signal
Keywords: آتورواستاتین; Atorvastatin; Doxorubicin; Oxidative stressALT, Alanine transaminase; AST, Aspartate transaminase; Ator, Atorvastatin; Bax, Bcl-2-associated X protein; BUN, Blood urea nitrogen; DOX, Doxorubicin; eNOS, Endothelial nitric oxide synthase; GSH, Reduced gluta
Keywords: آتورواستاتین; Micelles; Atorvastatin; Metastasis; Polyethylene glycol-s-s-vitamin E succinate; Reduction-responsive;
Keywords: آتورواستاتین; angiogram; atorvastatin; CIN; contrast-induced acute kidney injury; contrast-induced nephropathy; coronary angiography; PCI; percutaneous coronary intervention; rosuvastatin; simvastatin; statins;
Keywords: آتورواستاتین; Statin; Atorvastatin; Rosuvastatin; Diabetic nephropathy; Podocyte; Urinary podocyte;
Keywords: آتورواستاتین; Atorvastatin; Coronary disease; Low-density lipoprotein; Meta-regression; Randomized controlled trial; Statin;
Keywords: آتورواستاتین; Simvastatin; Atorvastatin; Collagen; Extracellular matrix;
Keywords: آتورواستاتین; Amlodipine; Atorvastatin; Metabolites; Liquid chromatography-tandem mass spectrometry; Bioequivalence;
Keywords: آتورواستاتین; Evidence based policy making; Bayesian analysis; Health insurance reimbursement; Hypercholesterolemia; Simvastatin; Atorvastatin;
Keywords: آتورواستاتین; Atorvastatin; Withdrawal; Cerebral cortex; Nitrosative damage; SOD;
Keywords: آتورواستاتین; Losartan; Atorvastatin; TGF-β1; tPA; PAI-1;
Keywords: آتورواستاتین; Atorvastatin; Rosuvastatin; Statins; Renal function; Proteinuria;
Keywords: آتورواستاتین; Atorvastatin; Pravastatin; Simvastatin; Acute lung injury; Inflammation; Oxidative stress;
Keywords: آتورواستاتین; atorvastatin; efficacy; hypercholesterolemia; tolerability;
Keywords: آتورواستاتین; Atorvastatin; Kidney; Aged rats; Pathology
Keywords: آتورواستاتین; atorvastatin; Brazil; cardiovascular; Colombia; cost-effectiveness; rosuvastatin; statins
Keywords: آتورواستاتین; atorvastatin; rosuvastatin; sepsis; simvastatin; statin; HR; hazard ratio; ICD-9-CM; International Classification of Diseases-9th Revision-Clinical Modification; LHID; Longitudinal Health Insurance Database; PS; propensity score;
Polymorphisms of ABCG2 and its impact on clinical relevance
Keywords: آتورواستاتین; ABCG2; SNPs; Gout; Cancer; Epilepsy; Atorvastatin; Alzheimer's disease;
Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk
Keywords: آتورواستاتین; Atorvastatin; Diabetes mellitus; Lipoprotein(a); PCSK9; CETP;
Dissolution and bioavailability enhancement of Atorvastatin: Gelucire semi-solid binary system
Keywords: آتورواستاتین; Atorvastatin; Dissolution; Solubility; Gelucire 50/13®; Gelucire 44/14®; Oral bioavailability;
Atorvastatin exerts inhibitory effect on endothelial senescence in hyperlipidemic rats through a mechanism involving down-regulation of miR-21-5p/203a-3p
Keywords: آتورواستاتین; Atorvastatin; Hyperlipidemia; Endothelial senescence; miR-21-5p; miR-203a-3p;
Spatial structure of atorvastatin and its complex with model membrane in solution studied by NMR and theoretical calculations
Keywords: آتورواستاتین; Atorvastatin; Statins; NMR; Nuclear overhauser effect; Dodecylphosphocholine micelles; Molecular complex;
Targeting NLRP3 inflammasome via acetylsalicylic acid: Role in suppressing hepatic dysfunction and insulin resistance induced by atorvastatin in naïve versus alcoholic liver in rats
Keywords: آتورواستاتین; AFL; alcoholic fatty liver; ALD; alcoholic liver disease; ALK; alkaline phosphatase; ALT; alaninetransaminase; ASA; acetylsalicylic acid; AST; aspartate transaminase; Bcl2; B cell lymphoma type 2; BSP; bromsulphthalein; COX-I; cyclooxygenase I; GSH; gluta
Polymorphisms in CYP450 Genes and the Therapeutic Effect of Atorvastatin on Ischemic Stroke: A Retrospective Cohort Study in Chinese Population
Keywords: آتورواستاتین; atherosclerosis; atorvastatin; CYP450 genes; ischemic stroke; single nucleotide polymorphism;
Protective effect of atorvastatin meditated by HMGCR gene on diabetic rats with atherosclerosis: An in vivo and in vitro study
Keywords: آتورواستاتین; HMGCR gene; Atorvastatin; Diabetic atherosclerosis; Protective effect; Gene silencing; Gene overexpression;
Atorvastatin in nano-particulate formulation abates muscle and liver affliction when coalesced with coenzyme Q10 and/or vitamin E in hyperlipidemic rats
Keywords: آتورواستاتین; Atorvastatin; CoQ 10; Nanoparticulate; Liver damage; Myopathy; Vitamin E;
A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) randomized trial
Keywords: آتورواستاتین; Apolipoprotein B; Atorvastatin; Glycated apolipoprotein B; High-density lipoprotein; Inflammatory cytokines; Low-density lipoprotein; Therapeutic targets; Type 2 diabetes mellitus; Very-low-density lipoprotein;